Could u post Max full comment by chance Ken
Post# of 154853
Quote:
Could u post Max full comment by chance
Quote:
Ken Chowder. Very good question Ken! As you pointed out, CRC is known to be a cold tumor, not much PD-L1 expression. We hope to see a similar impact on PD-L1 upregulation prospectively with Leronlimab, allowing patients potentially to benefit from ICIs. That option has been added in the CRC study. Best!

